Article ; Online: Recent advances in diabetes treatments and their perioperative implications.
Current opinion in anaesthesiology
2019 Volume 32, Issue 3, Page(s) 398–404
Abstract: Purpose of review: The implications for perioperative management of new oral antihyperglycemic medications and new insulin treatment technologies are reviewed.: Recent findings: The preoperative period represents an opportunity to optimize glycemic ... ...
| Abstract | Purpose of review: The implications for perioperative management of new oral antihyperglycemic medications and new insulin treatment technologies are reviewed. Recent findings: The preoperative period represents an opportunity to optimize glycemic control and potentially to reduce adverse outcomes. There is now general consensus that the optimal blood glucose target for hospitalized patients is approximately 106-180 mg/dl (6-10 mmol/l). Recommendations for the management of antihyperglycemic medications vary among national guidelines. It may not be necessary to cease all antihyperglycemic agents prior to surgery. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are associated with higher rates of ketoacidosis especially in acutely unwell and postsurgical patients. The clinical practice implications of new insulin formulations, and new systems for insulin delivery, are not clear. The optimal perioperative management of these will vary depending on local institutional factors such as staff skills and existing clinical practices. Improved hospital care delivery standards, quality assurance, process improvements, consistency in clinical practice, and coordinated multidisciplinary teamwork should be a major focus for improving outcomes of perioperative patients with diabetes. Summary: Sulfonylureas and SGLT2i should be ceased before moderate or major surgery. Other oral antihyperglycemic therapies may be continued or ceased. Complex patients and/or new therapies require specialized multidisciplinary management. |
|---|---|
| MeSH term(s) | Administration, Oral ; Blood Glucose/analysis ; Blood Glucose/drug effects ; Blood Glucose/physiology ; Diabetes Mellitus/blood ; Diabetes Mellitus/drug therapy ; Humans ; Hypoglycemic Agents/administration & dosage ; Hypoglycemic Agents/adverse effects ; Insulin/administration & dosage ; Patient Care Planning/organization & administration ; Patient Care Team/organization & administration ; Perioperative Care/methods ; Perioperative Care/standards ; Postoperative Complications/blood ; Postoperative Complications/diagnosis ; Postoperative Complications/etiology ; Postoperative Complications/prevention & control ; Practice Guidelines as Topic ; Surgical Procedures, Operative/adverse effects |
| Chemical Substances | Blood Glucose ; Hypoglycemic Agents ; Insulin |
| Language | English |
| Publishing date | 2019-02-20 |
| Publishing country | United States |
| Document type | Journal Article ; Review |
| ZDB-ID | 645203-6 |
| ISSN | 1473-6500 ; 0952-7907 |
| ISSN (online) | 1473-6500 |
| ISSN | 0952-7907 |
| DOI | 10.1097/ACO.0000000000000735 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 2564: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.